Stringent application of minimum-change-filtering and verification of identified DNA methylation and mRNA expression findings allowed identification of asthma-specific target genes like BAT3 and NEU1 and offers potential new avenues for patient stratification and personalized therapy. This evidence concerns the gene NEU1 and asthma.